475 related articles for article (PubMed ID: 30510552)
1. Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.
Humbert L; Cornu M; Proust-Lemoine E; Bayry J; Wemeau JL; Vantyghem MC; Sendid B
Front Immunol; 2018; 9():2570. PubMed ID: 30510552
[TBL] [Abstract][Full Text] [Related]
2. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.
Kisand K; Bøe Wolff AS; Podkrajsek KT; Tserel L; Link M; Kisand KV; Ersvaer E; Perheentupa J; Erichsen MM; Bratanic N; Meloni A; Cetani F; Perniola R; Ergun-Longmire B; Maclaren N; Krohn KJ; Pura M; Schalke B; Ströbel P; Leite MI; Battelino T; Husebye ES; Peterson P; Willcox N; Meager A
J Exp Med; 2010 Feb; 207(2):299-308. PubMed ID: 20123959
[TBL] [Abstract][Full Text] [Related]
3. Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Ng WF; von Delwig A; Carmichael AJ; Arkwright PD; Abinun M; Cant AJ; Jolles S; Lilic D
J Allergy Clin Immunol; 2010 Nov; 126(5):1006-15, 1015.e1-4. PubMed ID: 20934207
[TBL] [Abstract][Full Text] [Related]
4. Pattern recognition receptor expression is not impaired in patients with chronic mucocutanous candidiasis with or without autoimmune polyendocrinopathy candidiasis ectodermal dystrophy.
Hong M; Ryan KR; Arkwright PD; Gennery AR; Costigan C; Dominguez M; Denning DW; McConnell V; Cant AJ; Abinun M; Spickett GP; Swan DC; Gillespie CS; Young DA; Lilic D
Clin Exp Immunol; 2009 Apr; 156(1):40-51. PubMed ID: 19196253
[TBL] [Abstract][Full Text] [Related]
5. IL-22 neutralizing autoantibodies impair fungal clearance in murine oropharyngeal candidiasis model.
Bichele R; Kärner J; Truusalu K; Smidt I; Mändar R; Conti HR; Gaffen SL; Peterson P; Laan M; Kisand K
Eur J Immunol; 2018 Mar; 48(3):464-470. PubMed ID: 29150834
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy and other primary immunodeficiency diseases help to resolve the nature of protective immunity against chronic mucocutaneous candidiasis.
Kisand K; Peterson P
Curr Opin Pediatr; 2013 Dec; 25(6):715-21. PubMed ID: 24240291
[TBL] [Abstract][Full Text] [Related]
7. Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications.
Kisand K; Lilic D; Casanova JL; Peterson P; Meager A; Willcox N
Eur J Immunol; 2011 Jun; 41(6):1517-27. PubMed ID: 21574164
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)--a diagnostic and therapeutic challenge.
Jääskeläinen J; Perheentupa J
Pediatr Endocrinol Rev; 2009 Dec; 7(2):15-28. PubMed ID: 20118890
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients.
Sarkadi AK; Taskó S; Csorba G; Tóth B; Erdős M; Maródi L
J Clin Immunol; 2014 Feb; 34(2):181-93. PubMed ID: 24493573
[TBL] [Abstract][Full Text] [Related]
10. Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model.
Ahlgren KM; Moretti S; Lundgren BA; Karlsson I; Ahlin E; Norling A; Hallgren A; Perheentupa J; Gustafsson J; Rorsman F; Crewther PE; Rönnelid J; Bensing S; Scott HS; Kämpe O; Romani L; Lobell A
Eur J Immunol; 2011 Jan; 41(1):235-45. PubMed ID: 21182094
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome.
Kisand K; Peterson P
Ann N Y Acad Sci; 2011 Dec; 1246():77-91. PubMed ID: 22236432
[TBL] [Abstract][Full Text] [Related]
12. Impaired dendritic cell maturation and cytokine production in patients with chronic mucocutanous candidiasis with or without APECED.
Ryan KR; Hong M; Arkwright PD; Gennery AR; Costigan C; Dominguez M; Denning D; McConnell V; Cant AJ; Abinun M; Spickett GP; Lilic D
Clin Exp Immunol; 2008 Dec; 154(3):406-14. PubMed ID: 19037923
[TBL] [Abstract][Full Text] [Related]
13. [Autoimmune polyendocrinopathy and chronic mucocutaneous candidiasis].
Proto G; Leoni S; Torossi I; Mazzolini A; Grimaldi F; Bertolissi F
Minerva Med; 1992; 83(7-8):475-8. PubMed ID: 1522973
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.
Fierabracci A; Arena A; Toto F; Gallo N; Puel A; Migaud M; Kumar M; Chengappa KG; Gulati R; Negi VS; Betterle C
J Endocrinol Invest; 2021 Apr; 44(4):661-677. PubMed ID: 32767280
[TBL] [Abstract][Full Text] [Related]
15. Chronic mucocutaneous candidiasis - an immunological mystery.
Rabson AR
S Afr Med J; 2007 Nov; 97(11 Pt 3):1190-2. PubMed ID: 18250935
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED) due to AIRET16M mutation in a consanguineous Greek girl.
Kollios K; Tsolaki A; Antachopoulos C; Moix I; Morris MA; Papadopoulou M; Roilides E
J Pediatr Endocrinol Metab; 2011; 24(7-8):599-601. PubMed ID: 21932610
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients.
Garelli S; Dalla Costa M; Sabbadin C; Barollo S; Rubin B; Scarpa R; Masiero S; Fierabracci A; Bizzarri C; Crinò A; Cappa M; Valenzise M; Meloni A; De Bellis AM; Giordano C; Presotto F; Perniola R; Capalbo D; Salerno MC; Stigliano A; Radetti G; Camozzi V; Greggio NA; Bogazzi F; Chiodini I; Pagotto U; Black SK; Chen S; Rees Smith B; Furmaniak J; Weber G; Pigliaru F; De Sanctis L; Scaroni C; Betterle C
J Endocrinol Invest; 2021 Nov; 44(11):2493-2510. PubMed ID: 34003463
[TBL] [Abstract][Full Text] [Related]
18. Delay in the Diagnosis of APECED: A Case Report and Review of Literature from Iran.
Jamee M; Mahdaviani SA; Mansouri D; Azizi G; Joneidi N; Ghaffaripour H; Eskandarzade S; Ghaini M; Marjani M; Moniri A; Migaud M; Casanova J; Puel A; Velayati A
Immunol Invest; 2020 Apr; 49(3):299-306. PubMed ID: 31588815
[TBL] [Abstract][Full Text] [Related]
19. Oral mucous squamous cell carcinoma-an anticipated consequence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
Böckle BC; Wilhelm M; Müller H; Götsch C; Sepp NT
J Am Acad Dermatol; 2010 May; 62(5):864-8. PubMed ID: 20304522
[TBL] [Abstract][Full Text] [Related]
20. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
